Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2105-2105
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
George Doumat, Darine Daher, Morgan Bou Zerdan, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 704-719
Open Access | Times Cited: 21
Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy
Simon N. Mbugua
Bioinorganic Chemistry and Applications (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 25
Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review
Arinjay Jain, Sankha Bhattacharya
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Engineering metal-organic framework nanoparticles trigger pyroptosis to boost colon cancer immunotherapy
Xiang Wang, Xufeng Lu, Xinxin Yang, et al.
Materials & Design (2024) Vol. 238, pp. 112731-112731
Open Access | Times Cited: 5
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
Iram Fatima, Rizwan Ahmad, Susmita Barman, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 6, pp. 1046-1058
Closed Access | Times Cited: 4
Drug Repurposing in Cancer Therapy
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 4
An in vitro characterization and cytotoxic evaluation of mesoporous delivery of celecoxib on anticancer activity
Sayani Bhattacharyya, Reena Inas Fernandaes
European journal of parenteral & pharmaceutical sciences (2025)
Closed Access
Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy
Laurenţia Galeş, Leyla Forsea, Diana M. Mitrea, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1239-1239
Open Access | Times Cited: 18
Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
Tarapong Srisongkram, Natthida Weerapreeyakul
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 669-669
Open Access | Times Cited: 18
Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer
Yufang Hou, Fang Zhang, Jinbao Zong, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1126-1144
Closed Access | Times Cited: 3
Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells
Sofía Madeline Osorio-Pérez, Carolina Estrada‐Meza, Luis M. Ruiz‐Manriquez, et al.
Genes (2023) Vol. 14, Iss. 9, pp. 1730-1730
Open Access | Times Cited: 6
Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights
Zhe Liu, Ilias Georgakopoulos-Soares, Nadav Ahituv, et al.
Life Sciences (2023) Vol. 316, pp. 121413-121413
Closed Access | Times Cited: 5
Novel indole–chalcone platinum(IV) complexes as tubulin polymerization inhibitors to overcome oxaliplatin resistance in colorectal cancer
Xinguang Cao, Rui Li, Hui Wang, et al.
Journal of Molecular Structure (2022) Vol. 1272, pp. 134169-134169
Closed Access | Times Cited: 8
Iron Overloading Potentiates the Antitumor Activity of 5-Fluorouracil by Promoting Apoptosis and Ferroptosis in Colorectal Cancer Cells
Bilal Rah, Jasmin Shafarin, Asima Karim, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3763-3780
Open Access | Times Cited: 1
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
lncRNA VLDLR-AS1 Gene Expression in Colorectal Cancer in Patients from East Azerbaijan Province, Iran
Amin Moqadami, Alireza Ahmadi, Mohammad Khalaj‐Kondori
Jentashapir Journal of Cellular and Molecular Biology (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 3
In Silico Screening and Docking Analysis of a Few Drugs against Proteins Expressed in Colon Cancer
Ravi Vital Kandisa, Todupunuri Varun Sai, Rangisetti Naga Prudhvi Teja
International Journal for Research in Applied Science and Engineering Technology (2024) Vol. 12, Iss. 1, pp. 25-29
Open Access
Recent updates of clinical trials for colorectal cancer
Vipul Prajapati, Salona Roy, Shraddha Shinde, et al.
Elsevier eBooks (2024), pp. 411-456
Closed Access
Computational biology approaches for drug repurposing
Tanya Waseem, Tausif Ahmed Rajput, Muhammad Saqlain Mushtaq, et al.
Progress in molecular biology and translational science (2024), pp. 91-109
Closed Access
Repurposing Drugs for Overcoming Therapy Resistance in Colon Cancer – A Review
Mahdi Darvishi, Amir Chekeni, Mohammad Fazelhosseini, et al.
Journal of Angiotherapy (2024) Vol. 8, Iss. 2
Open Access
Imidazole-based hydrazones as potent anti-colon cancer agents: Design, synthesis, biological evaluation and computational studies
Michael Tapera, Eylül Doğan, Kader Şahin, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139240-139240
Closed Access
Polipose Adenomatosa Familiar (PAF) e seu manejo cirúrgico
Mickaelle Caroline Ferreira Moraes, Bárbara Sofia Brito Pinheiro
Journal Archives of Health (2024) Vol. 5, Iss. 3, pp. e2376-e2376
Open Access
Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors
Yareli L. Rojas-Salazar, Emiliano Gómez-Montañez, Jorge Rojas-Salazar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12840-12840
Open Access
New targets for old drugs
Navanath Kumbhar, M.A. Aparna, Snehal K. Nimal, et al.
Elsevier eBooks (2023), pp. 315-349
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top